In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Biosite, Medarex, & Lilly in drug discovery alliance

Executive Summary

Point-of-care diagnostics company Biosite Diagnostics and Medarex (monoclonal antibodies) will use Trans-Phage Technology to create fully human antibodies to genomic targets that Eli Lilly provides annually over a three-year period.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
    • Transgenics
    • Large Molecule
      • Antibodies
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register